sulforaphane/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases working memory performance
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Finally, the SFN intake group demonstrated improvements in processing speed and working memory performance compared to the placebo intake group.”
Quoted verbatim from Brain Training and Sulforaphane Intake Interventions Separately Improve Cognitive Performance in Healthy Older Adults, Whereas a Combination of These Interventions Does Not Have More Beneficial Effects: Evidence from a Randomized Controlled Trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- Three capsules per day containing 30 mg glucoraphanin (SFN precursor) versus 0 mg in placebo
- Population
- Healthy Japanese older adults aged 60-80; 2x2 factorial in which every participant also played either a brain-training game or an active-control game, balanced across the SFN and placebo arms; pooled across game arms
Brain Training and Sulforaphane Intake Interventions Separately Improve Cognitive Performance in Healthy Older Adults, Whereas a Combination of These Interventions Does Not Have More Beneficial Effects: Evidence from a Randomized Controlled Trial.2021PMID:33503851Industry fundedPermalink
Keep reading
- Everything the graph holds on sulforaphane
- Every compound studied against Working memory performance
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PJW2PG7BC0JGTXW9QWE4XT